20 results
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
27 Feb 24
MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
5:23pm
medical training (M.D. and Ph.D.) at the University of Medicine and Pharmacy Cluj, Romania, and University of Bern, Switzerland. He holds multiple medical
DRS
MAIA
MAIA Biotechnology Inc
1 Jun 23
Draft registration statement
12:00am
profiles for our clinical trials
and upon any commercialization of any of our product candidates. Inadequate training in recognizing or managing … and appropriately incentivize qualified individuals, generate sufficient sales leads, provide adequate training to sales and marketing personnel, oversee
424B4
MAIA
MAIA Biotechnology Inc
25 Apr 23
Prospectus supplement with pricing info
7:45pm
of any of our product candidates. Inadequate training in recognizing or managing the potential side effects of our product candidates could result … sales leads, provide adequate training to sales and marketing personnel, oversee the compliance of sales and marketing functions, and effectively
DEF 14A
mig uk4qoid3tvuit
19 Apr 23
Definitive proxy
4:06pm
DRS
rbhxnvj b6z
23 Dec 22
Draft registration statement
12:00am
424B4
zegwtq 1u52xt8
29 Jul 22
Prospectus supplement with pricing info
8:31am
S-1
cs8x 3mdtoo9zkrswir5
8 Apr 22
IPO registration
8:21pm
DRS/A
1k48t
22 Dec 21
Draft registration statement (amended)
12:00am
DRS
o4azcur66wi0wq c5
15 Oct 21
Draft registration statement
12:00am
- Prev
- 1
- Next